Equine Herpesvirus Immunity
- By Kimberly S. Brown
- Oct 24, 2008
When we consider our goals in controlling equine herpesvirus-1, owners and veterinarians want to minimize respiratory disease, prevent abortion, and prevent myelitis (neurologic disease). We want to control viremia to decrease the amount of virus in the blood, and decrease the most serious effects of this infection
Paul Lunn, BVMS, MS, PhD, head of the Department of Clinical Sciences at Colorado State University, discussed immunity’s role in the neurologic form of equine herpesvirus-1 at a meeting hosted by the C.L. Davis Foundation and the American Association of Veterinary Laboratory Diagnosticians and sponsored by Fort Dodge Animal Health.
This free report provides the horse owner and caretaker with an overview of vaccine studies and controlling equine herpesvirus-1.
- EHV-1 Inactivated Vaccine Efficacy Tested (AAEP 2011)
- Neurologic EHV-1: An Overview
- Diagnosing Neurologic EHV-1: Back to Basics
- EHV-1 Outbreak: Case Total Holding Steady
- EHV-1 Outbreak: Additional Cases Reported Over Weekend
- EHV-1 Outbreak: Veterinarians Still On Alert
- EHV-1 Outbreak: Several New Cases Reported
- EHV-1 Outbreak: The Watch for Cases Continues
- EHV-1 Outbreak: Number of Confirmed Cases Rising
- EHV-1 Outbreak: State Veterinarians Monitoring Closely